These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26479518)

  • 1. Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.
    Kalman LV; Agúndez J; Appell ML; Black JL; Bell GC; Boukouvala S; Bruckner C; Bruford E; Caudle K; Coulthard SA; Daly AK; Del Tredici A; den Dunnen JT; Drozda K; Everts RE; Flockhart D; Freimuth RR; Gaedigk A; Hachad H; Hartshorne T; Ingelman-Sundberg M; Klein TE; Lauschke VM; Maglott DR; McLeod HL; McMillin GA; Meyer UA; Müller DJ; Nickerson DA; Oetting WS; Pacanowski M; Pratt VM; Relling MV; Roberts A; Rubinstein WS; Sangkuhl K; Schwab M; Scott SA; Sim SC; Thirumaran RK; Toji LH; Tyndale RF; van Schaik R; Whirl-Carrillo M; Yeo K; Zanger UM
    Clin Pharmacol Ther; 2016 Feb; 99(2):172-85. PubMed ID: 26479518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
    Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
    Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
    Caudle KE; Dunnenberger HM; Freimuth RR; Peterson JF; Burlison JD; Whirl-Carrillo M; Scott SA; Rehm HL; Williams MS; Klein TE; Relling MV; Hoffman JM
    Genet Med; 2017 Feb; 19(2):215-223. PubMed ID: 27441996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the readiness of physicians for pharmacogenomics testing: an empirical assessment.
    Amara N; Blouin-Bougie J; Bouthillier D; Simard J
    Pharmacogenomics J; 2018 Apr; 18(2):308-318. PubMed ID: 28607504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.
    Pratt VM; Cavallari LH; Del Tredici AL; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2021 Sep; 23(9):1047-1064. PubMed ID: 34118403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for Clinical Warfarin Genotyping Allele Selection: A Report of the Association for Molecular Pathology and the College of American Pathologists.
    Pratt VM; Cavallari LH; Del Tredici AL; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2020 Jul; 22(7):847-859. PubMed ID: 32380173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added Value of Clinical Sequencing: WGS-Based Profiling of Pharmacogenes.
    Caspar SM; Schneider T; Meienberg J; Matyas G
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
    van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
    Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics in psychiatry: translating research into clinical practice.
    Malhotra AK; Zhang JP; Lencz T
    Mol Psychiatry; 2012 Jul; 17(8):760-9. PubMed ID: 22083729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.
    Bielinski SJ; Olson JE; Pathak J; Weinshilboum RM; Wang L; Lyke KJ; Ryu E; Targonski PV; Van Norstrand MD; Hathcock MA; Takahashi PY; McCormick JB; Johnson KJ; Maschke KJ; Rohrer Vitek CR; Ellingson MS; Wieben ED; Farrugia G; Morrisette JA; Kruckeberg KJ; Bruflat JK; Peterson LM; Blommel JH; Skierka JM; Ferber MJ; Black JL; Baudhuin LM; Klee EW; Ross JL; Veldhuizen TL; Schultz CG; Caraballo PJ; Freimuth RR; Chute CG; Kullo IJ
    Mayo Clin Proc; 2014 Jan; 89(1):25-33. PubMed ID: 24388019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Variation among Pharmacogenes in the Sardinian Population.
    Idda ML; Zoledziewska M; Urru SAM; McInnes G; Bilotta A; Nuvoli V; Lodde V; Orrù S; Schlessinger D; Cucca F; Floris M
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges to integrating pharmacogenetic testing into medication therapy management.
    Haga SB; Allen LaPointe NM; Moaddeb J
    J Manag Care Spec Pharm; 2015 Apr; 21(4):346-52. PubMed ID: 25803768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing.
    Haga SB; Kantor A
    Health Aff (Millwood); 2018 May; 37(5):717-723. PubMed ID: 29733708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TPMT and NUDT15 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase.
    Pratt VM; Cavallari LH; Fulmer ML; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2022 Oct; 24(10):1051-1063. PubMed ID: 35931343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.
    Hess GP; Fonseca E; Scott R; Fagerness J
    Genet Res (Camb); 2015 Jun; 97():e13. PubMed ID: 26030725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
    Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
    J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying an equity lens to pharmacogenetic research and translation to under-represented populations.
    Luczak T; Stenehjem D; Brown J
    Clin Transl Sci; 2021 Nov; 14(6):2117-2123. PubMed ID: 34268895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaborative Counseling Considerations for Pharmacogenomic Tests.
    Zierhut HA; Campbell CA; Mitchell AG; Lemke AA; Mills R; Bishop JR
    Pharmacotherapy; 2017 Sep; 37(9):990-999. PubMed ID: 28672074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recommendations for performing pharmacogenetic tests in drug monographs in Canada, France and the United States].
    Marquot G; Frison C; Lebel D; Bussières JF; Métras MÉ
    Ann Pharm Fr; 2020 Sep; 78(5):447-457. PubMed ID: 32777298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalizing medicine with clinical pharmacogenetics.
    Scott SA
    Genet Med; 2011 Dec; 13(12):987-95. PubMed ID: 22095251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.